Investigation of causal relationships between cortical structure and osteoporosis using two-sample Mendelian randomization

Cereb Cortex. 2024 Jan 31;34(2):bhad529. doi: 10.1093/cercor/bhad529.

Abstract

The mutual interaction between bone characteristics and brain had been reported previously, yet whether the cortical structure has any relevance to osteoporosis is questionable. Therefore, we applied a two-sample bidirectional Mendelian randomization analysis to investigate this relationship. We utilized the bone mineral density measurements of femoral neck (n = 32,735) and lumbar spine (n = 28,498) and data on osteoporosis (7300 cases and 358,014 controls). The global surficial area and thickness and 34 specific functional regions of 51,665 patients were screened by magnetic resonance imaging. For the primary estimate, we utilized the inverse-variance weighted method. The Mendelian randomization-Egger intercept test, MR-PRESSO, Cochran's Q test, and "leave-one-out" sensitivity analysis were conducted to assess heterogeneity and pleiotropy. We observed suggestive associations between decreased thickness in the precentral region (OR = 0.034, P = 0.003) and increased chance of having osteoporosis. The results also revealed suggestive causality of decreased bone mineral density in femoral neck to declined total cortical surface area (β = 1400.230 mm2, P = 0.003), as well as the vulnerability to osteoporosis and reduced thickness in the Parstriangularis region (β = -0.006 mm, P = 0.002). Our study supports that the brain and skeleton exhibit bidirectional crosstalk, indicating the presence of a mutual brain-bone interaction.

Keywords: brain-bone axis; causal effect; cortical structure; osteoporosis; two-sample Mendelian randomization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain
  • Genome-Wide Association Study
  • Humans
  • Mendelian Randomization Analysis*
  • Nonoxynol
  • Osteoporosis* / diagnostic imaging
  • Osteoporosis* / genetics
  • Radiopharmaceuticals

Substances

  • Nonoxynol
  • Radiopharmaceuticals